2.4 Specimen Collection, Handling, Storage, & Transport

2.4 Specimen Collection, Handling, Storage, & Transport

Quick Answer: Collect before antimicrobials, use aseptic technique, label at the bedside with two patient identifiers, place in a closed leak-proof container marked with the biohazard symbol or color-coded red (OSHA 29 CFR 1910.1030), transport promptly in the correct medium, and never refrigerate CSF or anaerobic specimens. Specimens shipped off-site move as UN 3373 Category B under triple packaging.

The infection preventionist rarely collects specimens personally, but the a-IPC blueprint asks candidates to identify appropriate practices for collection, handling, storage, and transportation. That is because pre-analytical error is the leading cause of misleading microbiology, and misleading microbiology corrupts everything downstream: unnecessary antibiotics, unnecessary isolation, false healthcare-associated infection (HAI) attribution, and distorted standardized infection ratios.

---

The Pre-Analytical Chain

graph LR
    A["Right patient<br/>2 identifiers"] --> B["Right timing<br/>before antimicrobials"]
    B --> C["Right technique<br/>aseptic, adequate volume"]
    C --> D["Right container<br/>leak-proof, biohazard-labeled"]
    D --> E["Right transport<br/>medium, temperature, time"]
    E --> F["Accepted specimen<br/>reportable result"]

1. Timing relative to antimicrobials

Collect before the first dose whenever the patient's condition allows. A single dose of a beta-lactam can sterilize a bloodstream within hours, converting a diagnosable bacteremia into a culture-negative sepsis syndrome that is then treated empirically and broadly for days. Where therapy has already started, note it on the requisition so the laboratory can use resin-containing or antimicrobial-neutralizing bottles.

2. Technique and volume

• Blood cultures: disinfect skin with 2% chlorhexidine gluconate in 70% isopropyl alcohol and allow it to dry completely — contact time, not scrubbing, kills skin flora. Disinfect the bottle septum separately. Volume is the single strongest determinant of yield: 20–30 mL per set in adults, distributed across bottles. Draw two sets from two separate venipuncture sites, and avoid drawing through an existing catheter unless you are specifically evaluating a line infection with paired peripheral and central cultures.
• Contamination benchmark: facilities should hold blood-culture contamination below 3.0%, with high performers under 1.0%. Rising contamination is an IPC and quality signal, not just a laboratory problem, because contaminated cultures drive vancomycin starts and false CLABSI investigations.
• Wound specimens: aspirate purulent material or biopsy deep tissue. Superficial swabs of open ulcers grow colonizing flora and are of limited value; the same applies to swabbing sinus tracts.
• Never culture: Foley catheter tips (they always grow biofilm organisms and do not diagnose urinary tract infection) or vent-circuit condensate.

3. Labeling and identification

Label at the bedside, at the time of collection, using two patient identifiers. Pre-labeling containers before entering the room and labeling in the hallway afterward are both mislabeling events waiting to happen; a mislabeled specimen can trigger isolation of the wrong patient and a false HAI.

---

Containment: What OSHA Actually Requires

Under the Bloodborne Pathogens Standard (29 CFR 1910.1030), specimens of blood or other potentially infectious material must be placed in a container that:

1. Prevents leakage during collection, handling, processing, storage, transport, and shipping;
2. Is closed before being stored, transported, or shipped;
3. Is labeled with the biohazard symbol or color-coded red. (Within a facility that uses Universal Precautions on all specimens, the labeling requirement may be relaxed only if containers are recognizable as specimens and stay inside the facility.)
4. Receives secondary containment — a second leak-proof container — if the outside of the primary container becomes contaminated or if puncture is a risk.

Specimens must never be transported in a gloved hand through a corridor, in a pocket, or in an open basin.

---

Shipping Classification for Infectious Substances

When specimens leave the facility — to a reference laboratory, a public health laboratory, or an outbreak investigation partner — Department of Transportation and IATA rules apply, and the classification depends on what the material can do.

Exam Tip: Blueprint language calls this transportation of dangerous goods (TDG). If a stem describes routine patient specimens going to a reference lab, the answer is Category B / UN 3373 triple packaging — not Category A, which is reserved for cultures and a short list of high-consequence agents.

---

Transport Media, Temperature, and Time

Refrigeration is not universally protective. It preserves urine bacterial counts, but it kills the fastidious organisms that matter most in meningitis and destroys obligate anaerobes.

---

Specimen Rejection Criteria

The laboratory should reject, and the IP should support rejection of:

• Unlabeled, mislabeled, or illegibly labeled specimens
• Leaking containers or specimens with contaminated exteriors
• Specimens in the wrong medium — most commonly, tissue placed in formalin (which sterilizes it and destroys any chance of culture)
• Specimens exceeding transport time or stored at the wrong temperature
• Sputum with >10 squamous epithelial cells per low-power field (saliva, not lower respiratory secretions); a good specimen shows >25 polymorphonuclear cells and few squamous cells
• Duplicate specimens ordered within the same 24-hour window without clinical justification
• Formed stool submitted for Clostridioides difficile testing

Each rejection prevents a misleading result. When an IP sees the same rejection reason recurring on one unit, that is an education opportunity — a Domain 6 task that starts with a Domain 1 observation.